Tirzepatide for diabetic nerve pain
Treatments studied
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether a weekly injection called tirzepatide can improve nerve pain and numbness related to diabetes. It may help people with type 2 diabetes who have nerve problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had diabetes for less than 10 years.
- Your blood sugar (A1C) is between 7% and 10%.
- You have symptoms like numbness, tingling, or pain in your feet or hands from nerve damage.
- Your body mass index (BMI) is 27 or higher.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug trimetazidine can improve nerve damage symptoms in people with type 2 diabetes and diabetic neuropathy. It also looks at how the drug affects a substance in the blood called endothelin-1, which may be involved in nerve damage.
This trial tests whether tirzepatide, a medication that helps control blood sugar and weight, can safely improve how your body handles sugar when you have type 1 diabetes. The study looks at short-term effects and may help people who are overweight and use an insulin pump or automated system.
This trial studies tirzepatide to see if it can slow the progression of coronary artery plaque in people with type 2 diabetes. It uses special heart CT scans to track changes over time.
This trial tests an experimental pain drug called suzetrigine for people with diabetic peripheral neuropathy (nerve damage from diabetes that causes pain in the feet and legs). It aims to see if the drug can safely reduce pain over time.
This study tests a once-weekly medicine called tirzepatide to see if it helps control blood sugar and reduce weight in people with type 2 diabetes and obesity. If you qualify, you might get this treatment and be monitored for safety and satisfaction.
This trial tests an experimental medicine called suzetrigine to see if it can safely reduce pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It might be an option if you have had daily pain in both legs and current treatments haven't worked well enough.
Hear when a new Neuropathy, Small Fiber trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.